BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29665971)

  • 1. Dissecting the signaling features of the multi-protein complex GPCR/β-arrestin/ERK1/2.
    Carmona-Rosas G; Alcántara-Hernández R; Hernández-Espinosa DA
    Eur J Cell Biol; 2018 Jun; 97(5):349-358. PubMed ID: 29665971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of β-arrestin2 at Thr
    Cassier E; Gallay N; Bourquard T; Claeysen S; Bockaert J; Crépieux P; Poupon A; Reiter E; Marin P; Vandermoere F
    Elife; 2017 Feb; 6():. PubMed ID: 28169830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
    Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
    J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
    Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
    J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retromer stops beta-arrestin 1-mediated signaling from internalized cannabinoid 2 receptors.
    Nogueras-Ortiz C; Roman-Vendrell C; Mateo-Semidey GE; Liao YH; Kendall DA; Yudowski GA
    Mol Biol Cell; 2017 Nov; 28(24):3554-3561. PubMed ID: 28954865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Many faces of the GPCR-arrestin interaction.
    Kim K; Chung KY
    Arch Pharm Res; 2020 Sep; 43(9):890-899. PubMed ID: 32803684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.
    Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M
    Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter Three - Ubiquitination and Protein Turnover of G-Protein-Coupled Receptor Kinases in GPCR Signaling and Cellular Regulation.
    Penela P
    Prog Mol Biol Transl Sci; 2016; 141():85-140. PubMed ID: 27378756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the molecular architecture of a G protein-coupled receptor/β-arrestin/Erk module complex.
    Bourquard T; Landomiel F; Reiter E; Crépieux P; Ritchie DW; Azé J; Poupon A
    Sci Rep; 2015 Jun; 5():10760. PubMed ID: 26030356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing G protein-coupled receptor signalsomes using confocal immunofluorescence microscopy.
    Shenoy SK
    Methods Mol Biol; 2011; 756():333-42. PubMed ID: 21870237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.
    Peterson YK; Luttrell LM
    Pharmacol Rev; 2017 Jul; 69(3):256-297. PubMed ID: 28626043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
    Waters CM; Connell MC; Pyne S; Pyne NJ
    Cell Signal; 2005 Feb; 17(2):263-77. PubMed ID: 15494217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.
    Park JY; Lee SY; Kim HR; Seo MD; Chung KY
    Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.